HomeFULC • NASDAQ
add
Fulcrum Therapeutics Inc
Previous close
$7.44
Day range
$7.18 - $7.44
Year range
$2.43 - $13.70
Market cap
450.89M USD
Avg Volume
580.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 871.00K | 27.15% |
Operating expense | 9.86M | -2.63% |
Net income | -24.76M | 5.28% |
Net profit margin | -2.84K | 25.50% |
Earnings per share | -0.40 | 20.41% |
EBITDA | -27.48M | -0.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 236.22M | 16.41% |
Total assets | 257.69M | 13.68% |
Total liabilities | 22.50M | -18.89% |
Total equity | 235.19M | — |
Shares outstanding | 61.94M | — |
Price to book | 1.96 | — |
Return on assets | -26.08% | — |
Return on capital | -27.28% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -24.76M | 5.28% |
Cash from operations | -23.16M | -17.58% |
Cash from investing | 18.35M | 150.48% |
Cash from financing | 287.00K | 31.65% |
Net change in cash | -4.52M | 91.91% |
Free cash flow | -14.46M | -38.28% |
About
Founded
2015
Website
Employees
76